COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04383002


Column Value
Trial registration number NCT04383002
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Jennifer Lister

Contact
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Jennifer.Lister@uhn.ca

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-05-11

Recruitment status
Last imported at : April 12, 2022, 11 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: confirmed infection with covid-19 positive rt-pcr tracheal aspirate prior to treatment use of mechanical ventilation with or without ecmo male or female ages > 18 years < 14 days from symptom initiation to study enrolment and < 7 days from intubation to study enrolment

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

patients on other interventional clinical trials subjects diagnosed with congestive or unstable heart disease including heart failure, left ventricular dysfunction (lvef < 40 %) or myocardial damage, severe pulmonary hypertension and/or unstable hypertension subjects diagnosed with immunodeficiency hematology: patients with clinically significant anemia e.g. hemoglobin < 100 and thrombocytopenia e.g. platelets < 75 subjects with clinically significant history of, or active bleeding including active pulmonary or gastrointestinal bleeding hepatic function: patients with abnormal liver function defined as any two of the following alt >3x uln, ast >3x uln, total bilirubin < 1.5 x uln patient receiving drugs that have a contraindication with no e.g. use of a nitric oxide donor agent such as nitroglycerin or drugs known to increase methemoglobin such as lidocaine, prilocaine, benzocaine or dapsone at screening as relevant to the proposed study population pregnancy subjects with a known hypersensitivity to methylene blue, subjects with glucose-6-phosphate dehydrogenase (g6pd) deficiency known or suspected thalassemia, sickle cell disease, or other conditions associated with poor oxygen carrying capacity

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

University Health Network, Toronto

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Canada

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Critical disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

8: Critical disease at enrollment

Total sample size
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

21

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

COVID-19 PCR status at completion of treatment (day 7) from tracheal aspirate

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 1

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 890, "treatment_name": "Nitric oxide gas", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]